Pilot-scale evaluation of UV reactors' efficacy against in vitro infectivity of Cryptosporidium parvum oocysts: Evaluation of UV reactors against C. parvum oocysts by Entrala, Emilio, Garin, Yves J.F., Meneceur, Pascale, Hayat, Maud, Scherpereel, Guillaume, Savin, Cyril, Féliers, Cédric, Derouin, Francis

Get full text

Pilot-scale evaluation of UV reactors'efficacy against in vitro infectivity of Cryptosporidium parvum oocysts by ENTRALA, Emilio, GARIN, Yves J. F, MENECEUR, Pascale, HAYAT, Maud, SCHERPEREEL, Guillaume, SAVIN, Cyril, FELIERS, Cedric, DEROUIN, Francis

Get full text

Pilot-scale evaluation of UV reactors' efficacy against in vitro infectivity ofCryptosporidium parvum oocysts by Entrala, Emilio, Garin, Yves J.F., Meneceur, Pascale, Hayat, Maud, Scherpereel, Guillaume, Savin, Cyril, Féliers, Cédric, Derouin, Francis

Get full text

Pilot-scale evaluation of UV reactors' efficacy against in vitro infectivity of Cryptosporidium parvum oocysts by Entrala, Emilio, Garin, Yves J.F, Meneceur, Pascale, Hayat, Maud, Scherpereel, Guillaume, Savin, Cyril, Féliers, Cédric, Derouin, Francis

Get full text

Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial by Bylicki, Olivier, Guisier, Florian, Scherpereel, Arnaud, Daniel, Catherine, Swalduz, Aurélie, Grolleau, Emmanuel, Bernardi, Marie, Hominal, Stephane, Prevost, Jean.Briac, Pamart, Guillaume, Marques, Marie.Héléne, Cloarec, Nicolas, Deshayes, Simon, Raimbourg, Judith, Veillon, Rémi, Oulkhouir, Youssef, Audigier Valette, Clarisse, Subtil, Fabien, Chouaïd, Christos, Greillier, Laurent

Get full text

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial by Eberst, Guillaume, Anota, Amélie, Scherpereel, Arnaud, Mazieres, Julien, Margery, Jacques, Greillier, Laurent, Audigier-Valette, Clarisse, Moro-Sibilot, Denis, Molinier, Olivier, Léna, Hervé, Rivière, Frédéric, Monnet, Isabelle, Gounant, Valérie, Janicot, Henri, Gervais, Radj, Locher, Chrystelle, Charton, Emilie, Morin, Franck, Zalcman, Gérard, Westeel, Virginie

Get full text

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer by Makris, Demosthenes, Scherpereel, Arnaud, Copin, Marie Christine, Colin, Guillaume, Brun, Luc, Lafitte, Jean Jacques, Marquette, Charles Hugo

Get full text

P1.03-018 FDG-PET/CT in Patients with EGFR-Mutated NSCLC Treated with TKI. Can We Identify Early Lesions at Higher Risk of Progression? by Petyt, Gegory, Bellevre, Dimitri, Adens, Amaury, Lahousse, Hélèné, Collet, Guillaume, Hossein-Foucher, Claude, Baldacci, Simon, Dhalluin, Xavier, Willemin, Marie-Capucine, Baranzelli, Anne, Scherpereel, Arnaud, Cortot, Alexis

Get full text

P1.03-018 FDG-PET/CT in Patients with EGFR-Mutated NSCLC Treated with TKI. Can We Identify Early Lesions at Higher Risk of Progression?: Topic: Radiology by Petyt, Gegory, Bellevre, Dimitri, Adens, Amaury, Lahousse, Hélèné, Collet, Guillaume, Hossein-Foucher, Claude, Baldacci, Simon, Dhalluin, Xavier, Willemin, Marie-Capucine, Baranzelli, Anne, Scherpereel, Arnaud, Cortot, Alexis

Get full text

Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study by Alidjinou, Enagnon Kazali, Poissy, Julien, Ouafi, Mahdi, Caplan, Morgan, Benhalima, Ilyes, Goutay, Julien, Tinez, Claire, Faure, Karine, Chopin, Marie-Charlotte, Yelnik, Cécile, Lambert, Marc, Hober, Didier, Preau, Sébastien, Nseir, Saad, Engelmann, Ilka

Get full text